http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28337367

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article
endingPage e222
issn 1558-7673
issueIdentifier 2
pageRange e217-e222
publicationName Clinical Genitourinary Cancer
startingPage e217
bibliographicCitation Miyake H, Hara T, Ozono S, Fujisawa M. Impact of Prior Use of an Androgen Receptor-Axis-Targeted (ARAT) Agent With or Without Subsequent Taxane Therapy on the Efficacy of Another ARAT Agent in Patients With Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2017 Apr;15(2):e217–22. doi: 10.1016/j.clgc.2016.07.005. PMID: 27522450.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cae6cdf6349e03217d0e4b0f387782d7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750e27ff50a198843644793502b2e583
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1fbcc4d172ef345ee31350cf6afa235
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87a03b162b11b996a593a3af8264ee41
date 201704
identifier https://doi.org/10.1016/j.clgc.2016.07.005
https://pubmed.ncbi.nlm.nih.gov/27522450
isPartOf https://portal.issn.org/resource/ISSN/1558-7673
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32764
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Impact of Prior Use of an Androgen Receptor-Axis-Targeted (ARAT) Agent With or Without Subsequent Taxane Therapy on the Efficacy of Another ARAT Agent in Patients With Metastatic Castration-Resistant Prostate Cancer
discusses http://id.nlm.nih.gov/mesh/M0443608
http://id.nlm.nih.gov/mesh/M0577955
http://id.nlm.nih.gov/mesh/M0562608
http://id.nlm.nih.gov/mesh/M0016576
http://id.nlm.nih.gov/mesh/M0547064
http://id.nlm.nih.gov/mesh/M0002327
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0026444
http://id.nlm.nih.gov/mesh/M0014878
http://id.nlm.nih.gov/mesh/M0011897
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000069501Q000008
http://id.nlm.nih.gov/mesh/D064129Q000188
http://id.nlm.nih.gov/mesh/D043823Q000008
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D010669Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001549
http://id.nlm.nih.gov/mesh/D064129Q000378
http://id.nlm.nih.gov/mesh/D009570
http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D017430Q000378
http://id.nlm.nih.gov/mesh/D043823Q000627
http://id.nlm.nih.gov/mesh/D000069501Q000627
http://id.nlm.nih.gov/mesh/D009362
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D007610Q000378
http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D010669Q000008
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D010669Q000627
http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9821849
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15951529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81422

Total number of triples: 66.